Skip to main content
SpringerLink
Log in

A Review of the Effects of Moderate Alcohol Intake on Psychiatric and Sleep Disorders

  • Chapter
Recent Developments in Alcoholism

Part of the book series: Recent Developments in Alcoholism ((RDIA,volume 14))

Abstract

In this chapter we discuss the effects of moderate ethanol consumption on the treatment of psychiatric and sleep disorders. A review of the literature on the interactions of ethanol with neurotransmitters and psychotropic medications suggests that although ethanol affects the clinical course of psychiatric and sleep disorders by different mechanisms, it does so principally through perturbations it causes in the balance of central nervous system neurotransmitter systems, which may modify the clinical course of primary psychiatric and sleep disorders and undermine the therapeutic response to psychotropic medications. Neurotransmitter responses may also be manifested clinically by rebound phenomena, akin to a subsyndromal withdrawal, which affect sleep and precipitate anxiety and mood symptoms. In addition, ethanol also modifies the clearance and disposition of a variety of psychotropic metabolites and interferes with their clinical effectiveness.

We recommend that most psychiatric patients, and all patients with sleep disorders, should abstain from even moderate ethanol use, as this may adversely affect their clinical course and response to treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Mino Y, Tsuda T, Aoyama H, Ohara H: Relationship between alcohol use and depressive/anxiety symptoms among a general population: A review of literature. Arukoru Kenkyuto Yakabutsu Ison [Jpn J Alcohol Stud Drug Depend] 27(3):242–253, 1992.

    CAS  Google Scholar 

  2. Hyman SE, Nestler EJ: The Molecular Foundations of Psychiatry. Washington, DC, American Psychiatric Press, 1993.

    Google Scholar 

  3. Golding JM, Burnam MA, Wells KB, Benjamin B: Alcohol use, depressive symptoms, and cultural characteristics in two Mexican-American samples. Int J Addict 28(5):451–476, 1993.

    PubMed  CAS  Google Scholar 

  4. Haack MR, Harford TC, Parker DA Alcohol use and depression symptoms among female nursing students. Alcohol Clin Exp Res 12(3):365–367, 1988.

    PubMed  CAS  Google Scholar 

  5. Chait LD, Perry JL: Acute and residual effects of alcohol and marijuana, alone and in combination, on mood and performance. Psychopharmacology 115(3):340–349, 1994.

    Article  PubMed  CAS  Google Scholar 

  6. Castaneda R, Sussman N, Westreich L, et al: A review of the effects of moderate alcohol intake on the treatment of anxiety and mood disorders. J Clin Psychiatry 57:207–212, 1996.

    PubMed  CAS  Google Scholar 

  7. Ogata M, Mendelson JH, Mello NK, Majchroxicz E: Adrenal function and alcoholism Psychosom Med 33:159–180, 1971.

    PubMed  CAS  Google Scholar 

  8. Hoffman PL, Tabakoff B: Ethanol’s action on brain biochemistry, in Tarter RE, van Thiel DH, Edwards KL (eds): Alcohol and the Brain: Chronic Effects. New York, Plenum, 1985, pp 19–68.

    Google Scholar 

  9. Martin D, Swartzwendler HS: Ethanol inhibits release of excitatory amino acids from slices of hippocampal area CAI. Eur J Pharmacol 219:469–472, 1992.

    PubMed  CAS  Google Scholar 

  10. Tsai G, Gastfriend DR, Coyle JT The glutamatergic basis of human alcoholism. Am J Psychiatry 152:332–340, 1995.

    PubMed  CAS  Google Scholar 

  11. Sillanaukee P, Lf K, Harlin A, Martensson O: Plasma GABA-like activity in response to ethanol challenge in men at high risk for alcoholism. Biol Psychiatry 27(6):617–625, 1990.

    Google Scholar 

  12. Cummins JT, Sack M, von Hungren K: The effect of chronic ethanol on glutamate binding in human and rat brains. Life Sci 47(10):877–882, 1990.

    Article  PubMed  CAS  Google Scholar 

  13. Stefanini E, Frau M, Garau MG, Garau B: Alcohol-preferring rats have fewer dopamine D2 receptors in the limbic system. Alcohol Alcohol 27(2): 127–130, 1992.

    PubMed  CAS  Google Scholar 

  14. Schuckit M, Parker DC, Rossman LR: Ethanol-related prolactin responses and risk for alcoholism. Biol Psychiatry 18(10); 1153–1159, 1983.

    PubMed  CAS  Google Scholar 

  15. Grabbe JC, Merrill CM, Kim D, Belkap JK: Alcohol dependence and withdrawal: A genetic animal model. Ann Med 22(4):259–263, 1990.

    Google Scholar 

  16. Miller RJ: Multiple calcium channels and neuronal function. Science 235:46–52, 1987.

    PubMed  CAS  Google Scholar 

  17. Hoffman PL: Central nervous system effects of neurohypophyseal peptides, in Smith CS (ed): The Peptides. New York, Academic Press, 1987, pp 239–295.

    Google Scholar 

  18. Meyer HH: Zur Theorie der Alkoholnarkose: III. Der Einfluss wechselnder Temperature auf Wirkungesstarke und Teilunskoeffizient der Narkotica. Naunyn Scmiedebergs Arch Exp Pathol Pharmacol 46:338–346, 1990.

    Google Scholar 

  19. Lovinger DM, White G, Weight FF: Ethanol inhibits NMDA-activated ion current in hippo-campal neurons. Science 243:1721–1724, 1989.

    PubMed  CAS  Google Scholar 

  20. Nutt D, Glue P: Monoamines and alcohol. Br J Addict 8:327–338, 1986.

    Google Scholar 

  21. Nestoros JN: Ethanol specifically potentiates GABA-mediated neurotransmission in feline cerebral cortex. Science 209:708–710, 1980.

    PubMed  CAS  Google Scholar 

  22. Tabakoff B, Hoffman PL: Alcohol interactions with brain opiate receptors. Life Sci 32:197–204, 1983.

    Article  PubMed  CAS  Google Scholar 

  23. Nevo I, Hamon M: Neurotransmitter and neuromodulatory mechanisms involved in alcohol abuse and alcoholism. Neurochem Int 26(4):305–336, 1995.

    Article  PubMed  CAS  Google Scholar 

  24. Suzdak PD, Glowa JN, Schwartz RD, et al: A selective imidazobenzodiazepine antagonist of ethanol in the rat. Science 234:1243–1247, 1986.

    PubMed  CAS  Google Scholar 

  25. Khatami S, Hoffman PL, Shibuya T, Salafsky B: Selective effects of ethanol on opiate receptors subtypes in the brain. Neuropharmacology 26:1503–1507, 1987.

    Article  PubMed  CAS  Google Scholar 

  26. Davis VE, Walsh MJ: Alcohol, amines and alkaloids: A possible biochemical basis for alcohol addiction. Science 167:1005–1007, 1970.

    PubMed  CAS  Google Scholar 

  27. Vaillant GE: Natural history of male psychological health: VIII. Antecedent of alcoholism and “orality.” Am J Psychiatry 137(2):181–186, 1980.

    PubMed  CAS  Google Scholar 

  28. Brown GL, Goodwin FK: Human aggression: A biological perspective, in Reid WH, Dorr D, Walker JI, Bonner JW (eds): Unmasking the Psychopath. New York, Norton, 1986, 55–61.

    Google Scholar 

  29. Stuss DT, Benson DF: The Frontal Lobes. New York, Raven Press, 1986.

    Google Scholar 

  30. Blumer D, Benson DF: Personality changes with frontal and temporal lobe lesions, in Benson DF, Blumer D (eds): Psychiatric Aspects of Neurologic Disease. New York, Grune & Stratton, 1975, pp 116–128.

    Google Scholar 

  31. Goldstein DB, Chin JH: Interaction with biological membrane. Fed Proc 40:1073–1076, 1981.

    Google Scholar 

  32. Tabakoff B, Hoffman PL: Biochemical pharmacology of alcohol, in Meltzer HY (ed): Psychopharmacology: The Third Generation of Progress. New York, Raven Press, 1987, pp 1521–1526.

    Google Scholar 

  33. Castaneda R, Cushman P Jr: Alcohol withdrawal: A review of clinical management. J Clin Psychiatry 50(8):278–283, 1989.

    PubMed  CAS  Google Scholar 

  34. Schuckit MA, Risch SC, Gold EO: Acute ethanol ingestion in sons of alcoholics results in lower plasma levels of ACTH than in sons of non-alcoholics. Am J Psychiatry 145(11):1391–1395, 1988.

    PubMed  CAS  Google Scholar 

  35. Waltman C, McCaul ME, Wand GS: Adrenocorticotropin responses following administration of ethanol and ovine corticotropin-releasing hormone in the sons of alcoholics and control subjects. Alcohol Clin Exp Res 18(4):826–830, 1994.

    PubMed  CAS  Google Scholar 

  36. Castaneda R, Lifshutz H, Westreich L, Galanter M: Concurrent cocaine withdrawal is associated with reduced severity of alcohol withdrawal. Compr Psychiatry 36(6):441–447, 1995.

    Article  PubMed  CAS  Google Scholar 

  37. Boutros NN, Bowers MB Jr: Chronic substance-induced psychotic disorders: State of the literature. JNeuropsychiatry Clin Neurosci 8:262–269, 1996.

    CAS  Google Scholar 

  38. Noordsy DL, Drake RE, Teague GB, et al: Subjective experiences related to alcohol use among schizophrenics. JNeurons Mental Dis 179(7):410–414, 1991.

    CAS  Google Scholar 

  39. Fadda F, Mosca E, Columbo G, Gessa G: Effect of spontaneous ingestion of ethanol on brain dopamine metabolism. Life Sci 44:281–287, 1989.

    Article  PubMed  CAS  Google Scholar 

  40. Krystal JH, Kerper LP, Seibyl JP, et al: Subanesthetic effects of the NMDA antogonist ketamine in human. Arch Gen Psychiatry 51:199–214, 1994.

    PubMed  CAS  Google Scholar 

  41. Olney JAW, Farber NB: Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 52:988–1007, 1995.

    Google Scholar 

  42. Benes FM: Altered glutamatergic and GABAergic mechanisms in the cingulate cortex of the schizophrenic brain. Arch Gen Psychiatry 52:1015–1017, 1995.

    PubMed  CAS  Google Scholar 

  43. Sohya M: Pathophysiological mechanisms possibly involved in the development of alcohol hallucinosis. Addiction 2:292–290, 1990.

    Google Scholar 

  44. Sohya M: Psychopathological characteristics in alcohol hallucinosis and paranoid schizophrenia. Acta Psychiatr Scand 81(3):255–259, 1990.

    Google Scholar 

  45. Horrobin DF, Mark MS, Hilman H, et al: Fatty acid levels in the brains of schizophrenics and normal controls. Biol Psychiatry 30:795–805, 1991.

    Article  PubMed  CAS  Google Scholar 

  46. Sohya M, Bondje B, Peuker B, Achenheil M: Spiperone binding capacity in lymphocytes of patients with alcohol and drug induced psychosis: Preliminary results. J Stud Alcohol 55(4):503–507, 1994.

    Google Scholar 

  47. Kabes J, Shondia V, Maholdivak K, Sosnom Z: Piracetam effective in alcohol psychosis: Double-blind, crossover, placebo-controlled comparison. Activats Nervosa Superior 27(1):66–67, 1985.

    Google Scholar 

  48. Anandatheerthavarada HK, Shankar SK, Bhamre S, et al: Induction of brain cytochrome P-450 111E1 by chronic ethanol treatment. Brain Res 601:279–285, 1993.

    Article  PubMed  CAS  Google Scholar 

  49. Lane EA, Guthrie S, Linnoila M: Effects of ethanol on drug and metabolite pharmacokinetics. Clin Pharmacokinet 10(3):228–247, 1985.

    PubMed  CAS  Google Scholar 

  50. Sonic SD, Bamrah JS, Krska J: Effects of alcohol on serum fluphenazine levels in stable chronic schizophrenics. Hum Psychopharmacol 6(4):301–306, 1991.

    Google Scholar 

  51. D’Mello DA, Boltz MK, Msibi B: Relationship between concurrent substance abuse in psychiatric patients and neuroleptic dosage. Am J Drug Alcohol Abuse 21(2):257–265, 1995.

    Google Scholar 

  52. National Institute on Alcoholism: Alcohol Alert. No 27 PH355. Washington, DC, author, 1995.

    Google Scholar 

  53. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC, author, 1994.

    Google Scholar 

  54. Herz A: Endogenous opioid systems and alcohol addiction. Psychopharmacology 129:99–111, 1997.

    Article  PubMed  CAS  Google Scholar 

  55. Schildkraut JJ: The cathecholamine hypothesis of depression: A review of supporting evidence. Am J Psychiatry 122:509–522, 1965.

    PubMed  CAS  Google Scholar 

  56. Costa E: Benzodiazepines and neurotransmitters. Arzneimittel-Forschung 30:858–861, 1980.

    PubMed  CAS  Google Scholar 

  57. Carroll BJ, Feinberg M, Greden JF, et al: A specific laboratory test for the diagnosis of melancholia: Standardization, validation, and clinical utility. Arch Gen Psychiatry 38:15–22, 1981.

    PubMed  CAS  Google Scholar 

  58. Nishikawa T, Scatton B: Neuroanatomical site of the inhibitory influence of anxiolytic drugs on central serotonergic transmission. Brain Res 371:123–132, 1986.

    Article  PubMed  CAS  Google Scholar 

  59. Chamey DS, Bremmer JD, Redmond E Jr: Noradrenergic neural substrates for anxiety and fear: Clinical associations based on preclinical research, in Bloom FE, Kupfer DJ (eds): Psychopharmacology: The Fourth Generation of Progress. New York, Raven Press, 1995, pp 387–395.

    Google Scholar 

  60. Calapai G, Mazzaglia G, Sautebin L, et al: Inhibition of nitric oxide formation reduces voluntary alcohol consumption in the rat. Psychopharmacology 125:398–401, 1996.

    Article  PubMed  CAS  Google Scholar 

  61. Persson MG, Gustafsson LE: Ethanol can inhibit nitric oxide production. Eur J Pharmacol 224:99–100, 1992.

    Article  PubMed  CAS  Google Scholar 

  62. Merikangas KR, Angst J, Eaton W, Canino G, Rubio-Stipec M, Wacker H, et al: Comorbidity and boundaries of affective disorders with anxiety disorders and substance misuse: Results of an international task force. Brit J Psych 30(Suppl): 58–67, 1996.

    Google Scholar 

  63. Wells JC, Tien AY, Garrison R, Eaton WW: Risk factors for the incidence of social phobia as determined by the Diagnostic Interview Schedule in a population-based study. Acta Psychiatr Scand 90:84–90, 1994.

    PubMed  CAS  Google Scholar 

  64. Major LF, Ballenger JC, Goodwin FK, Brown GL: Cerebrospinal fluid homovanillic acid in male alcoholics: Effects of disulfiram. Biol Psychiatry 12:635–642, 1977.

    PubMed  CAS  Google Scholar 

  65. Borg S, Weinholdt T Bromocriptine in the treatment of the alcohol withdrawal syndrome. Acta Psychiatr Scand 65:101–111, 1982.

    PubMed  CAS  Google Scholar 

  66. Mereu G, Fadda F, Gessa GL: Ethanol stimulates the firing rate of nigral dopaminergic neurons in unanesthetized rats. Brain Res 292:63–69, 1984.

    Article  PubMed  CAS  Google Scholar 

  67. Hoffman PL, Tabakoff B: Ethanol’s action on brain biochemistry, in Tarter RE, van Thiel DH, Edwards KL (eds): Alcohol and the Brain: Chronic Effects. New York: Plenum Press, 1985, pp 19–68.

    Google Scholar 

  68. Schuckit MA: Alcohol and depression: A clinical perspective (review). Acta Psychiatr Scand 377(Suppl):28–32, 1994.

    CAS  Google Scholar 

  69. Hasin DS, Glick H: Depressive symptoms and DSM-III-R alcohol dependence: General population results. Addiction 88(10):1431–1436, 1993.

    PubMed  CAS  Google Scholar 

  70. Golding JM, Burnam MA, Wells KB, Benjamin B: Alcohol use, depressive symptoms, and cultural characteristics in two Mexican-American samples. Int J Addict 28(5):451–476, 1993.

    PubMed  CAS  Google Scholar 

  71. Liebenluft E, Fiero PL, Bartko JJ, Rosaenthal NE: Depressive symptoms and the self-reported use of alcohol, caffeine, and carbohydrates in normal volunteers and four groups of psychiatric outpatients. Am J Psychiatry 150(2):294–301, 1993.

    Google Scholar 

  72. Castaneda R, Galanter M, Franco H: Self-medication among addicts with primary psychiatric disorders. Compr Psychiatry 30(1):80–83, 1989.

    Article  Google Scholar 

  73. Castaneda R, Galanter M, Lifshutz H, Franco H: Effects of drugs abuse on psychiatric symptoms among schizophrenics. Am J Drug Alcohol Abuse 17(3):313–320, 1991.

    PubMed  CAS  Google Scholar 

  74. Castaneda R, Lifshutz H, Galanter M, Franco H: An empirical assessment of the self-medication hypothesis. Compr Psychiatry 2:180–184, 1994.

    Google Scholar 

  75. Irwin M, Caldwell C, Smith TL, Brown S: Major depressive disorder, alcoholism and reduced natural killer cell cytotoxicity: Role of severity of depressive symptoms and alcohol consumption. Arch Gen Psychiatry 47(8):713–719, 1990.

    PubMed  CAS  Google Scholar 

  76. Moeller FG, Gillin JC, Irwin M, Golshan S: A comparison of sleep EEGs in patients with primary major depression and major depression secondary to alcoholism. J Affect Disord 27(1):39–42, 1993.

    Article  PubMed  CAS  Google Scholar 

  77. Powell BJ, Penick EC, Othmer E, et al: Prevalence of psychiatric syndromes among male alcoholics. J Clin Psychiatry 43:404–407, 1982.

    PubMed  CAS  Google Scholar 

  78. Rank DH: Subsyndromal symptomatic depression may include sleep disorders (letter). Psychiatry 56:329, 1995.

    CAS  Google Scholar 

  79. Brown SA, Inaba RK, Gillin C, et al: Alcoholism and affective disorder: Clinical course of depressive symptoms. Am J Psychiatry 152:45–52, 1995.

    PubMed  CAS  Google Scholar 

  80. Castaneda R, Sussman N, Westreich L, et al: A review of the effects of moderate alcohol intake on the treatment of anxiety and mood disorders. J Clin Psychiatry 57:207–212, 1996.

    PubMed  CAS  Google Scholar 

  81. Institute of Medicine: Broadening the Base of Treatment for Alcohol Problems. Washington DC, National Academy Press 1990.

    Google Scholar 

  82. Schrader GD: An attempt to validate Akiskal’s classification of chronic depression using cluster analysis. Compr Psychiatry 36:344–352, 1995.

    Article  PubMed  CAS  Google Scholar 

  83. Weissman MM, Myers JK: Clinical depression in alcoholism. Am J Psychiatry 137:372–373, 1980.

    PubMed  CAS  Google Scholar 

  84. Regier DA, Farmer ME, Rae DS, et al: Comorbidity of mental illness with alcohol and other drug abuse: Results from the epidemiologic catchment area (ECA) study. JAMA 264:2511–2518, 1990.

    Article  PubMed  CAS  Google Scholar 

  85. Khantzian EJ: The self-medication hypothesis of addictive disorders: Focus on heroin and cocaine dependence. Am J Psychiatry 142:1259–1264, 1985.

    PubMed  CAS  Google Scholar 

  86. Surman OS: Limits to the self-medication hypothesis of addictive disorders. Am J Psychiatry 142:1488, 1985.

    Google Scholar 

  87. Brady KT, Sohne SC: The relationship between substance abuse and bipolar disorder. Symposium on optimizing treatment in forms of biopolar disorder. J Clin Psychiatry 56(13):19–24, 1995.

    PubMed  Google Scholar 

  88. Goodwin FK, Jamison KR: Manic—Depressive Illness. New York, Oxford University Press, 1990.

    Google Scholar 

  89. Young LT, Cooke RG, Robb JC, et al: Anxious and non-anxious bipolar disorder. J Affect Disord 29(1):49–52, 1993.

    PubMed  CAS  Google Scholar 

  90. Pietraszek MH, Urano T, Sumioshik, et al: Alcohol induced depression: Involvement of serotonin. Alcohol Alcohol 26(2):155–159, 1991.

    PubMed  CAS  Google Scholar 

  91. Badawy AAB, Morgan CJ, Lovett JWT, et al: Decrease in circulating tryptophan to the brain after acute ethanol consumption by normal volunteers: Implications for alcohol-induced aggressive behavior and depression. Pharmacopsychiatry 28(2):93–97, 1999.

    Google Scholar 

  92. Borg S, Kvande H, Mossberg D, Valerious P, Sedvall G. Central nervous system nor-adrenaline metabolism and alcohol consumption in man. Pharmcol Biochem Behav 18:375–378, 1998.

    Google Scholar 

  93. Decker KP, Ries RK. Differential diagnosis and psychopharmacology of dual disorders. Psychiatr Clin North Am 16(4):703–718, 1993.

    PubMed  CAS  Google Scholar 

  94. Presskorn SH, Goodwin DW: Medical management of the depressed alcoholic patient. Int J Psychiatry Med 17(2):117–131, 1987.

    Google Scholar 

  95. Yules RB, Freedman DX, Chander KA: The effect of ethyl alcohol on man’s electroencephalographic sleep cycle. Neurophysiology 20:109–111, 1966.

    CAS  Google Scholar 

  96. Yules RB, Lippman ME, Freedman DX: Alcohol administration prior to sleep. The effect of EEG sleep stages. Arch Gen Pyschiatry 19:94–97, 1967.

    Google Scholar 

  97. Greenberg R, Perlman C: Delirium tremens and dreaming. Am J Psychiatry 124:133–142, 1967.

    PubMed  CAS  Google Scholar 

  98. Lester BK, Runder OH, Cowden LC, Williams HL: Chronic alcoholis, alcohol and sleep. Adv Exp Med Biol 35:261–279, 1972.

    Google Scholar 

  99. Johnson LC, Burdick JA, Smith J: Sleep during alcohol intake and withdrawal in the chronic alcoholic. Arch Gen Psychiatry 22:406–418, 1970.

    PubMed  CAS  Google Scholar 

  100. Zarcone VP, Schreier L, Mitchell G, et al: Sleep variables, cyclic AMP and biogenic amine metabolites after one day ethanol ingestion. J Stud Alcohol 41:318–324, 1980.

    PubMed  Google Scholar 

  101. Dijk DJ, Brunner DP, Aeschbach D, et al: The effects of ethanol on human sleep: EEG power spectra differ from those benzodiazepine receptor agonist. Neuropsychopharmacology 7(30):225–232, 1992.

    PubMed  CAS  Google Scholar 

  102. Suzdak PD, Glowa JN, Schwartz RD, et al: A selective imidazobenzodiazepine antagonist of ethanol in the rat. Science 167:1005–1007, 1970.

    Google Scholar 

  103. Zarcone VP: Sleep and alcoholism, in Weitzman ED (ed): Sleep Disorders: Intersections of Basic and Clinical Research. Vol 8. New York, Spectrum Press, 1982, pp 319–326.

    Google Scholar 

  104. Roth T, Roehrs T, Zorick F, Conway W: Pharmacological effects of sedative-hypnotics, narcotic analgesics, and alcohol during sleep. Med Clin North Am 69:1281–1288, 1985.

    PubMed  CAS  Google Scholar 

  105. Sahn SA, Lakshminarayan S, Pierson DJ, et al: Effects of ethanol on ventilatory responses to oxygen and carbon dioxyde in men. Clin Sci Mol Med 49:33–38, 1975.

    PubMed  CAS  Google Scholar 

  106. Johnstone RE, Reier CE: Acute repiratory effects of ethanol in man. Clin Pharmacol Ther 14:501–508, 1973.

    PubMed  CAS  Google Scholar 

  107. Bonora M, Sheilds G, Kauphs S, et al: Selective depression by ethanol of upper airwave respiratory motor activity in cats. Am Rev Respir Dis 130:156–161, 1984.

    PubMed  CAS  Google Scholar 

  108. Krol RC, Knuth SL, Bartlett D Selective reduction of genioglossal muscle activity by alcohol in normal human subjects. Am Rev Respir Dis 129247–250, 1984.

    PubMed  CAS  Google Scholar 

  109. Block AJ, Hellard DW, Slayton PC: Effect of alcohol ingestion on breathing of asymptomatic subjects. Arch Intern Med 147:1145–1147, 1987.

    Article  PubMed  CAS  Google Scholar 

  110. Mitler MM, Dawson A, Henriksen SJ, et al: Bedtime ethanol increases resistance of the upper airways and produces sleep apneas in asymptomatic snorers. Alcohol Clin Exp Res 12:801–805, 1988.

    PubMed  CAS  Google Scholar 

  111. Scrima L, Hartman PG, Thomas EE, et al: Sleep disordered breathing in non-obese 50–69-year-old male snorers and non-snorers: Effects of three alcohol doses. Sleep Res 21:263, 1992.

    Google Scholar 

  112. Issa FG, Sullivan CE: Alcohol, snoring, and sleep apnea. J Neurol Neurosurg Psychiatry 45:353–359, 1982.

    Article  PubMed  CAS  Google Scholar 

  113. Scrima L, Broudy M, Nay KN, et al: Increased severity of obstructive sleep apnea after bedtime alcohol ingestion: Diagnostic potential and proposed mechanism of action. Sleep 5:318–328, 1982.

    PubMed  CAS  Google Scholar 

  114. Easton PA, West P, Meatherall RC, et al: The effect of excessive ethanol ingestion on sleep in severe COPD. Sleep 10:224–233, 1987.

    PubMed  CAS  Google Scholar 

  115. Dolly FK, Block AJ: Increased ventricular ectopy and sleep apnea following ethanol ingestion in COPD patients. Chest 83(3):9–72, 1993.

    Google Scholar 

  116. Aldrich MS, Shipley JE: Alcohol use and periodic limb movements of sleep. Alcohol Clin Exp Res 17(1):192–196, 1993.

    PubMed  CAS  Google Scholar 

  117. Ruela, LM: Zolpidem and sleepwalking [letter]. J Clin Psychopharmacol 14(2):150, 1994.

    Google Scholar 

  118. Berlin RM, Qayyum U: Sleepwalking: Diagnosis and treatment through the life cycle. Psychosomatics 27(11):755–760, 1986.

    PubMed  CAS  Google Scholar 

  119. ReiterRJ: 1991 melatonin: The chemical expression of darkness. Mol Cell Endocrinol 69:C153–C158, 1991.

    Google Scholar 

  120. Nicholson AN, Spencer MB, Pascoe PA, Stone BM: Sleep after transmeridian flights. Lancet 2:1205–1208, 1986.

    PubMed  CAS  Google Scholar 

  121. Ekman AC, Leppaluoto J, Huttunen P, et al: Ethanol inhibits melatonin secretion in healthy volunteers in a dose-dependent randomized double blind cross-over study. J Clin Endocrinol Med 77(3):780–780, 1993.

    CAS  Google Scholar 

  122. Kabuto M, Namura I, Saitoh Y: Nocturnal enhancement of plasma melatonin could be suppressed by benzodiazepines in humans. Endocrinol Jpn 33:405–414, 1986.

    PubMed  CAS  Google Scholar 

  123. Moore-Ede MC, Czeisler CA, Richardson GS: Circadian timekeeping in health and disease. N Engl J Med 309:469–476, 1983.

    PubMed  CAS  Google Scholar 

  124. Valimaki M, Tuominen JA, Huhtanienmi I, Ylikakri R: The pulsatile secretion of gonadotrophins and growth hormone, and the biological activity of luteinizing hormone in men acutely intoxicated with ethanol. Alcoholism 14:928–931, 1990.

    PubMed  CAS  Google Scholar 

  125. Anand A, Charney DS, Delgado PL, et al: Neuroendocrine and behavioral responses to intravenous m-chlorophenylpiperazine (mCPP) in depressed patients and healthy comparison subjects. Am J Psychiatry 151:1626–1630, 1994.

    PubMed  CAS  Google Scholar 

  126. Jarrett DB, Kupfer DJ, Miewald JM, et al: Sleep-related growth hormone secretion is persistently suppressed in women without recurrent depression: A preliminary longitudinal analysis. JPsychiatr Res 28:211–223, 1994.

    CAS  Google Scholar 

  127. Fiasche R, Fideleff HL, Moisezowicz J, et al: Growth hormone neurosecretory dysfunction in major depressive illness. Psychoneuroendocrinology 20:727–733, 1995.

    Article  PubMed  CAS  Google Scholar 

  128. Cowen PJ, Power AC, Ware CJ, Anderson IM: 5-HT1A receptor in major depression. A neuroendocrine study with buspirone. Br J Psychiatry 154:372–379, 1994.

    Google Scholar 

  129. Roehrs T, Claiborue D, Knox M, Roth T: Residual sedating effects of ethanol. Alcohol Clin Exp Res 18(4):831–834, 1994.

    PubMed  CAS  Google Scholar 

  130. Pack AI, Pack AM, Todgman E, et al: Characteristics of crashes attributed to the driver having fallen asleep. Accid Anal Prev 27:769–775, 1995.

    Article  PubMed  CAS  Google Scholar 

  131. Zwyghuizen-Doorenbos A, Roehrs T, Lamphere J, et al: Increased daytime sleepiness enhances ethanol’s sedative effects. Neuropsychopharmacology 1:279–286, 1988.

    PubMed  CAS  Google Scholar 

  132. Bliwise NG: Factors related to sleep quality in healthy elderly women. Psychol Aging 7(1):83–88, 1992.

    Article  PubMed  CAS  Google Scholar 

  133. American Sleep Disorders Association: International Classification of Sleep Disorders: Diagnostic and Coding Manual. Rochester, MN, American Sleep Disorders Association, 1990.

    Google Scholar 

  134. Spielman AJ, Caruso LS, Glovinsky PB: A behavioral perspective on insomnia treatment. Psychiatry Clin North Am 10(4):541–553, 1987.

    CAS  Google Scholar 

  135. Erman MK Insomnia. Psychiatry Clin North Am 10(4):525–539, 1987.

    CAS  Google Scholar 

  136. Schaeffer KW, Parsons OA: Drinking practices and neuropsychological test performance in sober male alcoholics and social drinkers. Alcohol 3:175–179, 1986.

    PubMed  CAS  Google Scholar 

  137. Jones-Saumty DJ, Zeiner DJ: Psychological correlates of drinking behavior in social drinker college students. Alcohol Clin Exp Res 9:158–163, 1985.

    Article  PubMed  CAS  Google Scholar 

  138. Nolan Y, Johnston JA, Pincus AL: Personality and drunk driving: Identification of DUI types using the Hogan Personality Inventory. Psychol Assess 6:33–40, 1994.

    Google Scholar 

  139. McGlashan TH: Schizotypal personality disorder: Long-term follow-up perspectives. Chestnut Lodge follow-up study: VI. Arch Gen Psychiatry 43:329–334, 1986.

    PubMed  CAS  Google Scholar 

  140. Cleckley H: The Mask of Sanity. St. Louis, C.V. Mosby, 1964.

    Google Scholar 

  141. Collins JJ, Schlenger WE, Jordan BK Antisocial personality and substance abuse disorders. Bull Am Acad Psychiatry Law 16:187–198, 1988.

    PubMed  CAS  Google Scholar 

  142. Helzer JE, Pryzbeck TR: The co-occurrence of alcoholism with other psychiatric disorders in the general population and its impact on treatment. J Stud Alcohol 49:219–224, 1988.

    PubMed  CAS  Google Scholar 

  143. Ross HE, Glaser FB, Germanson T: The prevalence of psychiatric disorders in patients with alcohol and others drugs problems. Arch Gen Psychiatry 45:1023–1031, 1988.

    PubMed  CAS  Google Scholar 

  144. Cloninger CR, Sigvardsson S, Gilligan SB, et al: Genetic heterogeneity and the classification of alcoholism. Adv Alcohol Substance Abuse 7:3–16, 1988.

    CAS  Google Scholar 

  145. Irwin M, Schuckit M, Smith TL: Clinical importance of age at onset in type 1 and type 2 primary alcoholics. Arch Gen Psychiatry 47320–324, 1990.

    Google Scholar 

  146. Lamparski DM, Roy A, Nutt DJ, Linnoila M: The criteria of Cloninger et al. and Van Knorring et al. for subgrouping alcoholics: A comparison in a clinical population. Acta Psychiatr Scand 84:497–502, 1991.

    PubMed  CAS  Google Scholar 

  147. Gabel S, Stadler J, Bjorn J, Shindledecker R: Homovanillic acid and dopamine-beta-hydroxylase in male youth: Relationships with paternal substance abuse and antisocial behavior. Am J Drug Alcohol Abuse 21:363–378, 1995.

    PubMed  CAS  Google Scholar 

  148. Loranger AW: Dependent personality disorder. J Nerv Ment Disord 184:17–21, 1995.

    Google Scholar 

  149. DeObaldia R, Parsons OA, Yohman R: Minimal brain dysfunction symptoms claimed by primary and secondary alcoholics: Relation to cognitive functioning. Int J Neurosci 20:173–182, 1983.

    CAS  Google Scholar 

  150. DeObaldia R, Parsons OA: Relationship of neuropsychological performance to primary alcoholism and self-reported symptoms of childhood minimal brain dysfunction. J Stud Alcohol 45:386–392, 1984.

    CAS  Google Scholar 

  151. Jones KL, Smith DW, Ulleland CN, Streissguth AP: Pattern of malformation in offspring of chronic alcoholic mothers. Lancet 1:1267–1271, 1973.

    PubMed  CAS  Google Scholar 

  152. Reimherr FW, Wender PH, Wood DR Cerebrospinal fluid homovanillic acid and 5-hydroxyindole acetic acid in adults with attention deficit disorder, residual type (ADD,RT). Psychiatry Res 11:71–78, 1984.

    Article  PubMed  CAS  Google Scholar 

  153. Shaywitz SE, Cohen DJ, Bowers MB: CSF monoamine metabolites in children with minimal brain dysfunction: Evidence for alteration of brain dopamine. J Pediatr 90:67–71, 1977.

    PubMed  CAS  Google Scholar 

  154. Zametkin AJ, Nordahl TE, Gross M, et al: Cerebral glucose metabolism in adults with hyperactivity of childhood onset. N EnglJ Med 323:1361–1366, 1990.

    CAS  Google Scholar 

  155. Giedd JN, Castellanos X, Casey BJ, et al: Quantitative morphology of the corpus callosum in attention deficit hyperactivity disorder. Am J Psychiatry 151:565–669, 1994.

    Google Scholar 

  156. Wender PH: Attention Deficit Hyperactivity Disorder in Adults. New York, Oxford University Press, 1995.

    Google Scholar 

  157. Wood DR, Reimherr FW, Wender PH, Johnson GE: Diagnosis and treatment of minimal brain dysfunction in adults. Arch Gen Psychiatry 33:1533–1460, 1976.

    Google Scholar 

  158. Dufour MC, Archer L, Gordis E: Alcohol and the elderly. Clin Geriatr Med 8(1): 127–141, 1992.

    PubMed  CAS  Google Scholar 

  159. Wattis JP: Alcohol problems in the elderly. J Am Geriutr Soc 29(3):131–134, 1981.

    CAS  Google Scholar 

  160. Iliffe S, Haines A, Gallivan S, et al: Assessment of elderly people in general practice. BrJ Gen Pract 41(342):9–12, 1991.

    CAS  Google Scholar 

  161. Miller NS, Belkin BM, Gold MS: Alcohol and drug dependence among the elderly: Epidemiology, diagnosis, and treatment. Compr Psychiatry 32(2):153–165, 1991.

    Article  PubMed  CAS  Google Scholar 

  162. Rains VS, Ditzler TF: Alcohol use disorders in cognitively impaired patients referred for geriatric assessment. JAddict Dis 12(1):55–64, 1993.

    CAS  Google Scholar 

  163. Tyson PD, Schirmuly M: Memory enhancement after drinking ethanol: Consolidation, interference, or response bias? Physiol Behav 56(5):933–937, 1994.

    Article  PubMed  CAS  Google Scholar 

  164. Peterson JB, Rothfleisch J, Zelazo PD, Pihl RO: Acute alcohol intoxication and cognitive functioning. J Stud Alcohol 51(2):114–122, 1990.

    PubMed  CAS  Google Scholar 

  165. Elega HA: Alcohol and vigilance performance: A review. Psychopharmacology 118:233–249, 1995.

    Google Scholar 

  166. Post RB, Lott LA, Maddock RJ, Beede JI: An effect of alcohol on the distribution of spatial attention. J Stud Alcohol 57:260–266, 1991.

    Google Scholar 

  167. West R, Wilding J, French D, et al: Effect of low and moderate doses of alcohol on driving hazard perception latency and driving speed. Addiction 88:527–532, 1993.

    PubMed  CAS  Google Scholar 

  168. Tupler LA, Hege S, Ellinwood EH Jr: Alcohol pharmacodynamics in young-elderly adults contrasted with young and middle-aged subjects. Psychopharmacology 118(4):460–470, 1995.

    Article  PubMed  CAS  Google Scholar 

  169. Yesavage JA, Dolhert N, Taylor JL: Flight simulator performance of younger and older aircraft pilots: Effects of age and alcohol. J Am Geriatr Soc 42(6):577–582, 1994.

    PubMed  CAS  Google Scholar 

  170. Van Harten J, Stevens LA, Raghoebar M, et al: Fluvoxamine does not interact with alcohol or potentiate alcohol-related impairment of cognitive function. Clin Pharmacol Ther 52(4):427–435, 1992.

    PubMed  Google Scholar 

  171. Kerr JS, Fairweather DB, Mahendran R, Hindmarch I: The effects of paroxetine, alone and in combination with alcohol on psychomotor performance and cognitive function in the elderly. Int Clin Psychopharmacol 7(2):101–108, 1992.

    PubMed  CAS  Google Scholar 

  172. Carlen PL, McAndrews MP, Weiss RT, et al: Alcohol-related dementia in the institutionalized elderly. Alcohol Clin Exp Res 18(6):1330–1334, 1994.

    PubMed  CAS  Google Scholar 

  173. Victor M: Alcoholic dementia. Can JNeurol Sci 21(2):88–99, 1994.

    CAS  Google Scholar 

  174. Freund G, Ballinger WE: Loss of synaptic receptors can precede morphologic changes induced by alcoholism. Alcohol 1(Suppl):385–391, 1991.

    CAS  Google Scholar 

  175. Graves AB, van Duijn CM, Chandra V, et al: Alcohol and tobacco consumption as risk factors for Alzheimer’s disease: A collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol 20(Suppl)2:S48–57, 1991.

    Google Scholar 

  176. Teri L, Hughes JP, Larson EB: Cognitive deterioration in Alzheimer’s disease: Behavioral and health factors. J Gerontol 45(2):P58–63, 1990.

    Google Scholar 

  177. Jagger C, Clarke M, Stone A: Predictors of survival with Alzheimer’s disease: A community-based study. Psychol Med 25(1):171–177, 1995.

    Article  PubMed  CAS  Google Scholar 

  178. Freund G, Ballinger WE Jr: Alzheimer’s disease and alcoholism: Possible interactions. Alcohol 9(3):233–240, 1992.

    Article  PubMed  CAS  Google Scholar 

  179. Fein G, Biggins CA, MacKay S: Alcohol abuse and HIV infection have additive effects on frontal cortex function as measured by auditory evoked potential P3A latency. Biol Psychiatry 37(3):183–195, 1995.

    Article  PubMed  CAS  Google Scholar 

  180. Fink A, Hays RD, Moore AA, Beck JC: Alcohol-related problems in older persons: Determinants, consequences, and screening. Arch Intern Med 156(11):1150–1156, 1996.

    Article  PubMed  CAS  Google Scholar 

  181. Mereu 6, Faddle F, Oessa GL: Ethanol stimulates the firing rate of migral dopaminergic neurons in unanesthetized rats. Brain Res 292:63–69, 1984.

    Article  PubMed  CAS  Google Scholar 

  182. Lane EA, Guthrie S, Linnoila M: Effects of ethanol on drug and metabolite pharmacokinetics. ClinPharmacokinet 10(3):228–247, 1985.

    CAS  Google Scholar 

  183. Warrignton SJ, Ankier SI, Turner P: An evaluation of possible interactions between ethanol and trazodone or amitriptyline. Br J Clin Pharmacol 18(4)549–597, 1984.

    Google Scholar 

  184. Salvadori C, Ward C, Defrance R, Hopkins R: The pharmacokinetics of the antidepressant Tianeptine and its main metabolite in healthy humans—influence on alcohol coadministration. Fundament Clin Pharmacol 4(1):115-125, 1990.

    CAS  Google Scholar 

  185. Linnoila MI: Benzodiazepines and alcohol. J Psychiatr Res 2(Suppl24):121–127, 1990.

    Google Scholar 

  186. Bond AJ, Silveira JC: The combination of alprazolam and alcohol on behavioral aggression. J Stud Alcohol 11(Suppl):30–39, 1993.

    CAS  Google Scholar 

  187. Frewer LJ, Lader M. The effects of nefazodone, imipramine and placebo, alone and combined with alcohol in normal subjects. Int Clin Psychopharmacol 8:13–20, 1993.

    PubMed  CAS  Google Scholar 

  188. Kerr JS, Fairweather DB, Mahendran R, Hindmarch I: The effects of paroxetine, alone and in combination with alcohol on psychomotor performance and cognitive function in the elderly. Int Clin Psychopharmacol 7(2):101–108, 1992.

    PubMed  CAS  Google Scholar 

  189. Sussman N: Buspirone: A Review of the Literature. Princeton, NJ, Excerpta Medica, 1995.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, New York University School of Medicine, Bellevue Hospital Medical Center, New York, New York, 10016

    Ricardo Castaneda, Norman Sussman, Robert Levy, Mary O’Malley & Laurence Westreich

Authors
  1. Ricardo Castaneda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Norman Sussman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Robert Levy
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mary O’Malley
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Laurence Westreich
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Kluwer Academic Publishers

About this chapter

Cite this chapter

Castaneda, R., Sussman, N., Levy, R., O’Malley, M., Westreich, L. (1998). A Review of the Effects of Moderate Alcohol Intake on Psychiatric and Sleep Disorders. In: Recent Developments in Alcoholism. Recent Developments in Alcoholism, vol 14. Springer, Boston, MA. https://doi.org/10.1007/0-306-47148-5_9

Download citation

  • DOI: https://doi.org/10.1007/0-306-47148-5_9

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-306-45747-0

  • Online ISBN: 978-0-306-47148-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation